Home > Blog Tag

Blog Posts by Tag: Pathology

University of Southern California (USC) Department of Pathology and Laboratory Medicine — An Outreach Success Story

The University of Southern California (USC) Department of Pathology and Laboratory Medicine is one of the largest and most acclaimed in the country, with nationally and internationally renowned physicians on its staff. When the team at USC decided to open an outreach laboratory to expand their lab services to the community, the department chose XIFIN, Inc. as its pathology laboratory information...

Read


Lab Week 2021: Reflection and Gratitude

Once again, Lab week is upon us. As the second year celebrating Medical Laboratory Professionals Week (MLPW) in the midst of a global pandemic, it’s worth taking a moment to celebrate all our lab professionals and pathologists. Diagnostics is such a vital piece of the healthcare puzzle, and frontline laboratorians have been visible in unprecedented ways throughout the pandemic, but it is still...

Read


UHC Implements DEX Z-Code Requirements on Medicare Advantage Claims Starting June 1, 2021

this post was updated on June 1, 2021. In March 2021, United Healthcare announced an updated policy for Medicare Advantage plans, whereas they will be requiring providers to include the appropriate DEX Z-Code identifier on claims beginning June 1, 2021. United Healthcare has announced this policy update has been delayed and will not be implemented on June 1, 2021. Further communication will be...

Read


After Large Spikes in 2020, Diagnostic Laboratory Testing Volumes on the Decline

As XIFIN CEO Lâle White wrote in her recent LinkedIn article, the COVID-19 pandemic created many challenges for the diagnostic industry in 2020. In the preceding years, many laboratories were running lean with little excess capacity. With the surge in COVID-19 testing demand, labs had to quickly add capacity to handle the new testing volume. In addition, dynamic regulatory changes designed to...

Read


The Remaining 20%: The Critical Role Appeals Play in Profitability (Part 2)

This blog post is part two of the series. View Part One. View Part Two. The first installment of this three part series provides data on denial trends in the pathology, molecular, and the clinical laboratory marketplace. Understanding root causes for specific denials enables us to initiate a strategic, multi-tiered approach to appeals. Measuring outcomes on all attempts to recover revenue,...

Read


The Remaining 20%: The Critical Role Denials Play in Lost Revenue (Part 1)

This blog post is part one of the series. View Part Two. View Part Three. In revenue cycle management we’ve always been of the mindset that 60-80% of billing is clean when the order is received and relatively simple to do well; however, it is how the remaining percentage is tackled that will determine whether your efforts are truly successful. That could never be truer than with the climate we...

Read


UHC Announces Designated Diagnostic Provider Requirements for Coverage

On February 24, 2021, XIFIN learned that UHC has delayed the application deadline from February 28, 2021 to March 10, 2021. The go-live date of July 1, 2021 is still in place. Additional requests to confirm how places of service 81, 11, 19, 22 are impacted has been requested from UHC. XIFIN will provide additional updates as they are received. UHC recently announced plans to implement the...

Read


Digital Pathology Goes Mainstream

Enjoy the following content from our partner, Proscia. COVID-19 has disrupted laboratory medicine in many ways, causing a strong need for new testing, social distancing, and telemedicine.The pandemic has been especially challenging for pathology, which has remained mostly unchanged over the last 150 years. The field has held onto its traditional practices centering around a pathologist reading...

Read